Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer

This publication has 55 references indexed in Scilit:

• Association Between Nonsteroidal Anti-Inflammatory Drug Use and the Incidence of Pancreatic Cancer
  JNCI Journal of the National Cancer Institute, 2002
• Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin
  Oncogene, 2001
• STAT proteins: novel molecular targets for cancer drug discovery
  Oncogene, 2000
• Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors
  Oncogene, 2000
• STATs in oncogenesis
  Oncogene, 2000
• Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death
  Oncogene, 2000
• Hammerhead Ribozyme Specifically Inhibits Mutant K-ras mRNA of Human Pancreatic Cancer Cells
  Biochemical and Biophysical Research Communications, 1998
• No standard treatment is available for advanced pancreatic cancer
  European Journal Of Cancer, 1995
• A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
  Science, 1994
• Characterisation of a cell line (LCC-18) from a cultured human neuroendocrine-differentiated colonic carcinoma
  European Journal of Cancer and Clinical Oncology, 1991